227 related articles for article (PubMed ID: 25068731)
1. Synthesis of new isoxazoline derivatives from harmine and evaluation of their anti-Alzheimer, anti-cancer and anti-inflammatory activities.
Filali I; Bouajila J; Znati M; Bousejra-El Garah F; Ben Jannet H
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):371-6. PubMed ID: 25068731
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of New Harmine Isoxazoles and Evaluation of their Potential Anti-Alzheimer, Anti-inflammatory, and Anticancer Activities.
Filali I; Romdhane A; Znati M; Jannet HB; Bouajila J
Med Chem; 2016; 12(2):184-90. PubMed ID: 26362768
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, cytotoxic, anti-lipoxygenase and anti-acetylcholinesterase capacities of novel derivatives from harmine.
Filali I; Belkacem MA; Ben Nejma A; Souchard JP; Ben Jannet H; Bouajila J
J Enzyme Inhib Med Chem; 2016; 31(sup1):23-33. PubMed ID: 27028352
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel pyrazolopyrimidines derivatives as anticancer and anti-5-lipoxygenase agents.
Rahmouni A; Souiei S; Belkacem MA; Romdhane A; Bouajila J; Ben Jannet H
Bioorg Chem; 2016 Jun; 66():160-8. PubMed ID: 27179178
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of novel 1,2-oxazine-based small molecules that targets acetylcholinesterase.
Sukhorukov AY; Nirvanappa AC; Swamy J; Ioffe SL; Nanjunda Swamy S; Basappa ; Rangappa KS
Bioorg Med Chem Lett; 2014 Aug; 24(15):3618-21. PubMed ID: 24909082
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 5-benzylidenerhodanine-3-acetic acid derivatives as AChE and 15-LOX inhibitors.
Shafii N; Khoobi M; Amini M; Sakhteman A; Nadri H; Moradi A; Emami S; Saeedian Moghadam E; Foroumadi A; Shafiee A
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):389-95. PubMed ID: 26095345
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents.
Venugopala KN; Govender R; Khedr MA; Venugopala R; Aldhubiab BE; Harsha S; Odhav B
Drug Des Devel Ther; 2015; 9():911-21. PubMed ID: 25733811
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel β-carboline derivatives as selective AChE inhibitors with GSK-3β inhibitory property for the treatment of Alzheimer's disease.
Liu W; Liu X; Liu W; Gao Y; Wu L; Huang Y; Chen H; Li D; Zhou L; Wang N; Xu Z; Jiang X; Zhao Q
Eur J Med Chem; 2022 Feb; 229():114095. PubMed ID: 34995924
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of New Arylidene 2,5-Diketopiperazines and Evaluation of their Anti-Acetylcholinesterase, Anti-xanthine Oxidase, Anti-diabetic and Cytotoxic Activities.
Belkacem MA; Jannet HB; Ferhout H; Mzali L; Bouajila J
Med Chem; 2017; 13(8):744-752. PubMed ID: 28480832
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2/5-LOX inhibitors and antitumor agents.
Li Z; Wang ZC; Li X; Abbas M; Wu SY; Ren SZ; Liu QX; Liu Y; Chen PW; Duan YT; Lv PC; Zhu HL
Eur J Med Chem; 2019 May; 169():168-184. PubMed ID: 30877972
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Evaluation and Docking Studies of 5-oxo-5
Mphahlele MJ; Gildenhuys S; Agbo EN
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683761
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases.
Saeed A; Mahesar PA; Zaib S; Khan MS; Matin A; Shahid M; Iqbal J
Eur J Med Chem; 2014 May; 78():43-53. PubMed ID: 24675179
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of new anticancer and anti-inflammatory isoxazolines and aziridines from the natural (-)-deltoin.
Znati M; Debbabi M; Romdhane A; Ben Jannet H; Bouajila J
J Pharm Pharmacol; 2018 Dec; 70(12):1700-1712. PubMed ID: 30229910
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxic activity evaluation of some novel 1-(3-(aryl-4,5-dihydroisoxazol-5-yl)methyl)-4-trihalomethyl-1H-pyrimidin-2-ones in human cancer cells.
Lobo MM; Viau CM; Dos Santos JM; Bonacorso HG; Martins MA; Amaral SS; Saffi J; Zanatta N
Eur J Med Chem; 2015 Aug; 101():836-42. PubMed ID: 26275603
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel forskolin isoxazole derivatives with potent anti-cancer activity against breast cancer cell lines.
Burra S; Voora V; Rao CP; Vijay Kumar P; Kancha RK; David Krupadanam GL
Bioorg Med Chem Lett; 2017 Sep; 27(18):4314-4318. PubMed ID: 28838692
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel 1,2,3-triazole linked coumarinopyrazole conjugates as potent anticholinesterase, anti-5-lipoxygenase, anti-tyrosinase and anti-cancer agents.
Chekir S; Debbabi M; Regazzetti A; Dargère D; Laprévote O; Ben Jannet H; Gharbi R
Bioorg Chem; 2018 Oct; 80():189-194. PubMed ID: 29940340
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships of harmine derivatives as potential antitumor agents.
Cao R; Fan W; Guo L; Ma Q; Zhang G; Li J; Chen X; Ren Z; Qiu L
Eur J Med Chem; 2013 Feb; 60():135-43. PubMed ID: 23291116
[TBL] [Abstract][Full Text] [Related]
19. Further in vitro biological activity evaluation of amino-, thio- and ester-derivatives of avarol.
Tommonaro G; Pejin B; Iodice C; Tafuto A; De Rosa S
J Enzyme Inhib Med Chem; 2016 Aug; 31(4):684-6. PubMed ID: 26114310
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, molecular properties, anti-inflammatory and anticancer activities of novel 3-hydroxyflavone derivatives.
Znati M; Bordes C; Forquet V; Lantéri P; Ben Jannet H; Bouajila J
Bioorg Chem; 2019 Aug; 89():103009. PubMed ID: 31158579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]